Financing & Shareholding

Categories

Turnover: n.a.

Employees: 10 - 50

Region: n/a

Description

An innovative company is pioneering a high-capacity vector platform that enables gene therapy with large and multiple genes. Based on this gene therapy platform, the company is developing transformative drugs for the treatment of chronic, widespread diseases such as osteoarthritis and disc degeneration.

Contact

Philipp Löprick (Project Manager)

E-Mail Philipp.Loeprick@PortusCo.com